iSpecimen Inc. Net Income
iSpecimen Inc. (ISPC) reported Net Income of -$1.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-14
- iSpecimen Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$1.36M.
- iSpecimen Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$2.28M.
- iSpecimen Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$5.00M.
- iSpecimen Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$2.78M.
- iSpecimen Inc. net income (loss) attributable to parent for fiscal 2025 was -$10.49M.
- iSpecimen Inc. net income (loss) attributable to parent for fiscal 2024 was -$12.50M.
- iSpecimen Inc. net income (loss) attributable to parent for fiscal 2023 was -$11.10M.
- iSpecimen Inc. net income (loss) attributable to parent for fiscal 2022 was -$10.25M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.36M 10-Q · filed 2026-08-14 | -$3.64M 10-Q · filed 2026-08-14 | -$8.64M derived: sum of 3 quarters · filed 2026-08-14 | -$11.42M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.28M 10-Q · filed 2026-08-14 | -$7.28M derived: sum of 2 quarters · filed 2026-08-14 | -$10.06M derived: sum of 3 quarters · filed 2026-08-14 | -$11.10M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$7.78M derived: sum of 2 quarters · filed 2026-04-01 | -$8.83M derived: sum of 3 quarters · filed 2026-08-14 | -$10.49M 10-K · filed 2026-04-01 |
| 2025-09-30 | -$2.78M 10-Q · filed 2025-11-17 | -$3.83M derived: sum of 2 quarters · filed 2026-08-14 | -$5.49M 10-Q · filed 2025-11-17 | -$11.53M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.05M 10-Q · filed 2026-08-14 | -$2.71M 10-Q · filed 2026-08-14 | -$8.75M derived: sum of 3 quarters · filed 2026-08-14 | -$10.19M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.66M 10-Q · filed 2026-08-14 | -$7.71M derived: sum of 2 quarters · filed 2026-08-14 | -$9.15M derived: sum of 3 quarters · filed 2026-08-14 | -$11.25M derived: sum of 4 quarters · filed 2026-08-14 |
| 2024-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$7.49M derived: sum of 2 quarters · filed 2026-04-01 | -$9.60M derived: sum of 3 quarters · filed 2026-04-01 | -$12.50M 10-K · filed 2026-04-01 |
| 2024-09-30 | -$1.44M 10-Q · filed 2025-11-17 | -$3.55M derived: sum of 2 quarters · filed 2025-11-17 | -$6.45M 10-Q · filed 2025-11-17 | -$9.52M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$2.11M 10-Q · filed 2025-11-17 | -$5.01M 10-Q · filed 2025-08-14 | -$8.08M derived: sum of 3 quarters · filed 2025-11-17 | -$10.20M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-03-31 | -$2.90M 10-Q · filed 2025-11-17 | -$5.98M derived: sum of 2 quarters · filed 2025-11-17 | -$8.09M derived: sum of 3 quarters · filed 2025-11-17 | -$11.57M derived: sum of 4 quarters · filed 2025-11-17 |
| 2023-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | -$5.18M derived: sum of 2 quarters · filed 2025-04-14 | -$8.67M derived: sum of 3 quarters · filed 2025-04-14 | -$11.10M 10-K · filed 2025-04-14 |
| 2023-09-30 | -$2.11M 10-Q · filed 2024-11-07 | -$5.59M derived: sum of 2 quarters · filed 2024-11-07 | -$8.03M 10-Q · filed 2024-11-07 | -$10.19M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$3.48M 10-Q · filed 2024-11-07 | -$5.92M 10-Q · filed 2024-08-06 | -$8.08M derived: sum of 3 quarters · filed 2024-11-07 | -$11.17M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-03-31 | -$2.43M 10-Q · filed 2024-11-07 | -$4.59M derived: sum of 2 quarters · filed 2024-11-07 | -$7.69M derived: sum of 3 quarters · filed 2024-11-07 | -$10.29M derived: sum of 4 quarters · filed 2024-11-07 |
| 2022-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$5.26M derived: sum of 2 quarters · filed 2024-03-13 | -$7.86M derived: sum of 3 quarters · filed 2024-03-13 | -$10.25M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$3.10M 10-Q · filed 2023-11-02 | -$5.70M derived: sum of 2 quarters · filed 2023-11-02 | -$8.09M 10-Q · filed 2023-11-02 | -$10.14M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$2.61M 10-Q · filed 2023-11-02 | -$4.99M 10-Q · filed 2023-08-02 | -$7.04M derived: sum of 3 quarters · filed 2023-11-02 | -$8.59M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-03-31 | -$2.38M 10-Q · filed 2023-11-02 | -$4.43M derived: sum of 2 quarters · filed 2023-11-02 | -$5.99M derived: sum of 3 quarters · filed 2023-11-02 | -$7.38M derived: sum of 4 quarters · filed 2023-11-02 |
| 2021-12-31 | -$2.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$3.60M derived: sum of 2 quarters · filed 2023-03-30 | -$5.00M derived: sum of 3 quarters · filed 2023-03-30 | -$8.96M 10-K/A · filed 2023-03-30 |
| 2021-09-30 | -$1.55M 10-Q · filed 2022-11-08 | -$2.95M derived: sum of 2 quarters · filed 2022-11-08 | -$6.91M 10-Q · filed 2022-11-08 | -$8.50M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$1.39M 10-Q · filed 2022-11-08 | -$5.36M 10-Q · filed 2022-08-04 | -$6.95M derived: sum of 3 quarters · filed 2022-11-08 | -$8.20M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-03-31 | -$3.96M 10-Q · filed 2022-11-08 | -$5.56M derived: sum of 2 quarters · filed 2022-11-08 | -$6.80M derived: sum of 3 quarters · filed 2022-11-08 | -$6.98M derived: sum of 4 quarters · filed 2022-11-08 |
| 2020-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$2.84M derived: sum of 2 quarters · filed 2022-03-22 | -$3.01M derived: sum of 3 quarters · filed 2022-03-22 | -$4.65M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$1.25M 10-Q · filed 2021-11-04 | -$1.42M derived: sum of 2 quarters · filed 2021-11-04 | -$3.06M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$174.09K 10-Q · filed 2021-11-04 | -$1.81M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$1.64M 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |